Periodontal treatment and microbiome-targeted therapy in management of periodontitis-related nonalcoholic fatty liver disease with oral and gut dysbiosis

By sjmartinez • February 28, 2023

Kuraji R, Shiba T, Dong TS, Numabe Y, Kapila YL. Periodontal treatment and microbiome-targeted therapy in management of periodontitis-related nonalcoholic fatty liver disease with oral and gut dysbiosis. World J Gastroenterol. 2023 Feb 14;29(6):967-996. doi: 10.3748/wjg.v29.i6.967. PMID: 36844143; PMCID: PMC9950865.

Tags: Digestive Diseases, Dysbiosis, Metabolic syndrome, Microbiota, Nonalcoholic fatty liver disease, Periodontal disease, probiotics, Publications

From embedded interprofessional clinics to expanded alcohol-associated liver disease programs

Winder GS, Arab JP, Goswami Banerjee A, Bryce K, Fipps DC, Hussain F, Im G, Omary L, Patel AA, Patel S, Rubman S, Serper M,[...]

Expert recommendations to standardize transcriptomic analysis in inflammatory bowel disease clinical trials

Linggi B, Azucena S, Steere B, Verstockt B, Alsoud D, Casero D, McGovern D, Chan E, Smith MI, Ungaro F, Rieder F, Aden K, Shackelton[...]

Worsening Racial and Ethnic Disparities in Colorectal Cancer Screening Rates in United States Federally Qualified Health Centers

Zhao MY, Aaronson MRM, Singh V, De Silva SR, Badiee J, May FP. Worsening Racial and Ethnic Disparities in Colorectal Cancer Screening Rates in United[...]